JEREMY ALLEN: Open Payments
NPI 1447287115 · PELL CITY, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,299 in 51 payments from 8 companies in 2025. Trend: 2023 $236 · 2024 $1,703 · 2025 $1,299
Food & beverage: $1,288Education: $12
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 20 | $392 |
| Amgen Inc. | 14 | $234 |
| Otsuka America Pharmaceutical, Inc. | 6 | $227 |
| AstraZeneca Pharmaceuticals LP | 5 | $216 |
| Lilly USA, LLC | 1 | $122 |
| PFIZER INC. | 2 | $48 |
| ABBVIE INC. | 2 | $42 |
| Abbott Laboratories | 1 | $19 |
Products named: Ozempic, OTEZLA, REXULTI, ZEPBOUND, BREZTRI, FARXIGA, Rybelsus, QULIPTA.
Industry payments across AL — which companies pay providers there.
